Geographic Availability Available in all 50 states (eligibility for compounded meds varies by state) Clinical Oversight and Safety Licensed providers review each case
The injectable GLP-1 RAs liraglutide 3 mg once daily and semaglutide 2.4 mg once weekly have both gained a licence for weight loss, alongside lifestyle management, in obese/overweight people without T2D (SmPC, 2023b
Focus on Fiber and Protein : Fiber is an important nutrient linked to improved heart health, a lower risk of type 2 diabetes, lower body weight and improved gut health
Each adjustment is made with clarity, and every step is tied back to measurable outcomes
alcohol volumes are declining across beer, wine, and spirits The percentage of Americans who drink has dropped from 62% in 2023 to 54% in 2025, according to Gallup Younger consumers are drinking less frequently and more selectively GLP-1 drugs do not create these trendsbut they may accelerate them
Here are targeted protocols for the most common switching scenarios